LeMaitre Vascular, Inc. (LMAT)
84.56
+0.59
(+0.70%)
USD |
NASDAQ |
Dec 24, 12:47
LeMaitre Vascular SG&A Expense (TTM): 94.78M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Baxter International, Inc. | 2.89B |
| Integra LifeSciences Holdings Corp. | 708.95M |
| ResMed, Inc. | 1.011B |
| Perspective Therapeutics, Inc. | 31.53M |
| Xtant Medical Holdings, Inc. | 74.03M |